| Name | Title | Contact Details |
|---|
Ensho Therapeutics, Inc. is a privately held, clinical-stage biopharmaceutical company focused on developing breakthrough oral therapies for patients with inflammatory diseases. The companys initial focus is on a pipeline of oral, selective small molecule inhibitors of lymphocyte homing integrin α4β7 for IBD, a mechanism already validated by a commercially available antibody. Enshos assets were acquired from EA Pharma Co., Ltd., a subsidiary of Eisai Co., Ltd., that is focused on gastrointestinal disease. Ensho is preparing to initiate a Phase 2 clinical program in UC with NSHO-101, the lead asset in the companys pipeline.
We’re building a strong network of top-ranked dermatology practices, united into a physician-centered business. With PDP, patients win and care is better.
I-O Urology is the first and only remote patient monitoring system for urology. It replaces uroflows and subjective voiding diaries. Finally.
Fineman PR is a San Francisco, CA-based company in the Business Services sector.
Women'S Faculty Club Of Uc is a Berkeley, CA-based company in the Business Services sector.